Lymphoma, B-Cell
2 competing products in clinical development for Lymphoma, B-Cell.
Pipeline by Phase
Phase 22
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Valemetostat tosylate | Daiichi Sankyo | Phase 2 | Active | 39 |
| ONTAK (denileukin diftitox) | Eisai | Phase 2 | Completed | 35 |